Allarity Therapeutics
Clinical trials sponsored by Allarity Therapeutics, explained in plain language.
-
Experimental cancer combo tested in tiny, terminated trial
Disease control TerminatedThis early-stage trial tested a new drug called 2X-121, alone and combined with another drug called dovitinib, in 14 people with advanced solid tumors. The goal was to find the safest dose and check for side effects. The study was terminated early, so results are limited and no c…
Phase: PHASE1 • Sponsor: Allarity Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Experimental chemo drug tested for advanced breast cancer
Disease control TerminatedThis phase 2 trial tested the chemotherapy drug ixabepilone in 13 patients with metastatic breast cancer that had stopped responding to standard treatments. The goal was to see if the drug could shrink tumors or slow the disease. The study was terminated early, so the full result…
Phase: PHASE2 • Sponsor: Allarity Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC